Electrochemotherapy with cisplatin enhances local control after surgical ablation of fibrosarcoma in cats: an approach to improve the therapeutic index of highly toxic chemotherapy drugs

[1]  G. Citro,et al.  Evaluation of Cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs. , 2011, Journal of veterinary internal medicine.

[2]  P. Zahedi,et al.  Polymeric drug delivery systems for localized cancer chemotherapy , 2010, Drug delivery.

[3]  G. Citro,et al.  Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans , 2009, Journal of experimental & clinical cancer research : CR.

[4]  O. Scharovsky,et al.  Metronomic chemotherapy: changing the paradigm that more is better , 2009, Current oncology.

[5]  D. Brat,et al.  Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme , 2008, Journal of Neuro-Oncology.

[6]  C. Allen,et al.  Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer , 2008, Molecular Cancer Therapeutics.

[7]  R. Milner,et al.  Cisplatin: a review of toxicities and therapeutic applications. , 2008, Veterinary and comparative oncology.

[8]  G. Citro,et al.  Patterns of tumor response in canine and feline cancer patients treated with electrochemotherapy: preclinical data for the standardization of this treatment in pets and humans , 2007, Journal of Translational Medicine.

[9]  M. Johnston,et al.  A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. , 2007, Biomaterials.

[10]  Xiaomei Ma,et al.  Global Burden of Cancer , 2006, The Yale journal of biology and medicine.

[11]  W. Mark Saltzman,et al.  New Methods for Direct Delivery of Chemotherapy for Treating Brain Tumors , 2006, The Yale journal of biology and medicine.

[12]  G. Citro,et al.  Intraoperative versus postoperative electrochemotherapy in high grade soft tissue sarcomas: a preliminary study in a spontaneous feline model , 2006, Cancer Chemotherapy and Pharmacology.

[13]  I. Tannock,et al.  Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: repopulation as a cause of treatment failure? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  G. Citro,et al.  Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma , 2006, Melanoma research.

[15]  I. Tannock,et al.  Repopulation of cancer cells during therapy: an important cause of treatment failure , 2005, Nature Reviews Cancer.

[16]  D. Rischin,et al.  Strategies to overcome accelerated repopulation and hypoxia--what have we learned from clinical trials? , 2004, Seminars in oncology.

[17]  E. Douple,et al.  Biodegradable Cisplatin Polymer in Limb-Sparing Surgery for Canine Osteosarcoma , 2004, Annals of Surgical Oncology.

[18]  A. Porrello,et al.  Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of biphasic electric pulses. , 2003, Journal of experimental & clinical cancer research : CR.

[19]  Jessie L.-S. Au,et al.  Drug Delivery and Transport to Solid Tumors , 2003, Pharmaceutical Research.

[20]  B. Warkentin,et al.  Investigating the effect of cell repopulation on the tumor response to fractionated external radiotherapy. , 2003, Medical physics.

[21]  N. Kemeny,et al.  Intrahepatic arterial infusion of chemotherapy: clinical results. , 2002, Seminars in oncology.

[22]  M. Wientjes,et al.  Clinical aspects of drug delivery to tumors. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[23]  G. Gasparini,et al.  Metronomic scheduling: the future of chemotherapy? , 2001, The Lancet. Oncology.

[24]  M. Wientjes,et al.  Determinants of drug delivery and transport to solid tumors. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[25]  A J Davis,et al.  Repopulation of tumour cells between cycles of chemotherapy: a neglected factor. , 2000, The Lancet. Oncology.

[26]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[27]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[28]  A. Matsumura,et al.  Low peripheral lymphocyte count before focal radiotherapy plus concomitant temozolomide predicts severe lymphopenia during malignant glioma treatment. , 2010, Neurologia medico-chirurgica.

[29]  Alfonso Baldi,et al.  Potential role of electrochemotherapy for the treatment of soft tissue sarcoma: first insights from preclinical studies in animals. , 2008, The international journal of biochemistry & cell biology.